Dr. Jason Brayer, MD
Hematologist-Oncologist | Hematology & Oncology
12902 USF Magnolia Drive Tampa Florida, 33612About
Jason B. Brayer, MD, PhD, is a hematologist-oncologist who diagnoses and treats patients at Moffitt Cancer Center - Magnolia Campus in Tampa, FL. Furthermore, he is an Assistant Member of the H. Lee Moffitt Cancer Center & Research Institute. As a hematologist-oncologist, he has training and experience in the diagnosis, treatment, and prevention of blood diseases and cancers. Dr. Brayer’s professional journey spans four years, and he is an expert in treating multiple myeloma-plasma cell tumors. His clinical interests include the treatment of plasma cell disorders, such as Waldenstrom macroglobulinemia, multiple myeloma, and MGUS. Dr. Jason B. Brayer is also actively participating or leading clinical trials that investigate the development of immunotherapeutic approaches in multiple myeloma. To stay up to date in his field, he maintains active memberships with the American Society of Clinical Oncology, the American Association for Cancer Research, the American Society of Hematology, the Society for Immunotherapy of Cancer, and the Florida Society of Clinical Oncology.
Dr. Jason Brayer, MD's Videos
Education and Training
University of South Florida Morsani College of Medicine Medical Degree 2009
Board Certification
American Board of Internal Medicine
Provider Details
Areas of expertise and specialization
Professional Memberships
- American Society of Hematology
- American Association for Cancer Research
- American Society of Clinical Oncology
- Florida Society of Clinical Oncology
- Society for Immunotherapy of Cancer
Fellowships
- H. Lee Moffitt Cancer Center & Research Institute Hematology-Oncology 2015
Internships
- H. Lee Moffitt Cancer Center & Research Institute
Professional Society Memberships
- American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Florida Society of Clinical Oncology, Society for Immunotherapy of Cancer
Hobbies / Sports
- Tennis, Spending Time With Family
Favorite professional publications
- New England Journal of Medicine, Blood Journal, Science Translational Medicine, Nature Immunology Journal
Dr. Jason Brayer, MD's Practice location
Dr. Jason Brayer, MD's reviews
Write ReviewPatient Experience with Dr. Brayer
Media Releases
Get to know Hematology-Oncologist Dr. Jason Brayer, who serves the population of St. Petersburg, Florida.
Dr. Brayer graduated with his Medical Degree from the University of South Florida in 2009, giving him over a decade of experience in his field. After obtaining his Medical Degree then completed his Internal Medicine Residency with the University of South Florida. Wanting to further his training he then completed his Immunology fellowship with the La Jolla Institute of Allergy & Immunology followed by a Hematology/Oncology fellowship with H. Lee Moffit Cancer Center and Research Institute.
Dr. Brayer is dual certified in Hematology and Oncology by the American Board of Internal Medicine. To stay up to date in his field he remains a professional member of the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Florida Society of Clinical Oncology, and the Society for Immunotherapy of Cancer. He currently practices with Moffitt Cancer Center. He holds an expertise in Hematology, Oncology, Physician Scientist, Tumor Immunology, and Plasma Cell Displasia.
A hematologist-oncologist who is a physician who specializes in the diagnosis, treatment and/or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. They will be trained in hematology, the study of blood and oncology, the study of cancer, but will specialize in treating blood cancers, such as Hodgkins and non-Hodgkins lymphomas, leukemias and multiple myelomas. A hematologist-oncologist may also specialize in the management of solid tumors.
When not working he enjoys playing tennis and spending time with his family.
Recommended Articles
- Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission
4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
- Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux
Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
- Facts About Multiple Myeloma
Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...
- The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...